ReviewClinical cardiology2019

The effect of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists on cardiovascular disease in patients with type 2 diabetes.

Amit K Dey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.